Clear Filters The Role of Alpha-synuclein in Alzheimer’s Disease January 8, 2022 The Role of Alpha-synuclein in Alzheimer’s Disease Read More Leukodystrophy Therapy: How is Gain Therapeutics Developing First-in-class treatment for Krabbe Disease January 8, 2022 Leukodystrophy Therapy: How is Gain Therapeutics Developing First-in-class treatment for Krabbe Disease Read More Gaucher Disease & Parkinson’s: Understanding the Connection January 6, 2022 Gaucher Disease & Parkinson’s: Understanding the Connection Read More Gain Therapeutics: Revolutionary Drug Discovery with Physics, Biochem & Supercomputing December 16, 2021 Gain Therapeutics: Revolutionary Drug Discovery with Physics, Biochem & Supercomputing Read More Enzyme Targeting: Are Enzymes Good Therapeutic Targets for treating rare genetic diseases? December 16, 2021 Enzyme Targeting: Are Enzymes Good Therapeutic Targets for treating rare genetic diseases? Read More How is Gain Therapeutics targeting allosteric sites to create novel drugs? December 4, 2021 How is Gain Therapeutics targeting allosteric sites to create novel drugs? Read More The Role of AlphaFold in Solving Protein Misfolding Disorders November 25, 2021 The Role of AlphaFold in Solving Protein Misfolding Disorders Read More DeepMind AlphaFold: Revolutionizing Protein Folding Predictions November 20, 2021 DeepMind AlphaFold: Revolutionizing Protein Folding Predictions Read More What Is Protein Misfolding and How Gain Therapeutics Is Reversing It to Treat Disease November 16, 2021 What Is Protein Misfolding and How Gain Therapeutics Is Reversing It to Treat Disease Read More Corporate Presentation August 2024 Corporate Presentation Download
